RedHill Biopharma's market cap is currently $6.25M. The company's EPS TTM is $; its P/E ratio is ―; RedHill Biopharma is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 6.51M	$ 61.80M	$ 85.76M	$ 64.36M	$ 6.29M
Gross Profit	$ 3.05M	$ 28.46M	$ 36.35M	$ 27.47M	$ 4.03M
Operating Income	$ 12.63M	$ -42.84M	$ -81.14M	$ -63.68M	$ -43.20M
EBITDA	$ 26.31M	$ -42.84M	$ -63.03M	$ -54.94M	$ -40.78M
Net Income	$ 23.92M	$ -59.24M	$ -114.31M	$ -89.02M	$ -43.63M
Balance Sheet
Cash & Short-Term Investments	$ 6.36M	$ 19.98M	$ 38.00M	$ 29.79M	$ 47.87M
Total Assets	$ 23.05M	$ 158.87M	$ 181.19M	$ 180.24M	$ 74.10M
Total Debt	$ 1.17M	$ 122.69M	$ 87.81M	$ 86.90M	$ 3.81M
Net Debt	$ -4.40M	$ 102.72M	$ 58.34M	$ 57.61M	$ -25.21M
Total Liabilities	$ 20.98M	$ 207.27M	$ 172.31M	$ 166.38M	$ 14.10M
Stockholders' Equity	$ 2.07M	$ -48.40M	$ 8.88M	$ 13.86M	$ 60.00M
Cash Flow
Free Cash Flow	$ -35.83M	$ -29.38M	$ -65.16M	$ -102.35M	$ -40.95M
Operating Cash Flow	$ -35.82M	$ -29.18M	$ -65.05M	$ -48.58M	$ -40.75M
Investing Cash Flow	$ 4.00K	$ 8.30M	$ -8.14M	$ -35.65M	$ 5.16M
Financing Cash Flow	$ 21.44M	$ 11.45M	$ 73.46M	$ 84.37M	$ 35.51M

Currency in USD

RedHill Biopharma Earnings and Revenue History

Income Statement >

RedHill Biopharma Debt to Assets

Balance Sheet >

RedHill Biopharma Cash Flow

Cash Flow >

RedHill Biopharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing